BAXTER INTERNATIONAL INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
BAXTER INTERNATIONAL INC. (BAX) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $135.00 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-23.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2022-02-23
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2021-12-31 was $83.00M.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2021-09-30 was $28.00M.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2021-06-30 was $0.00.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2021-03-31 was $24.00M, a 500.00% increase year-over-year.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2021 was $135.00M, a 3275.00% increase from fiscal 2020.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2020 was $4.00M.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2018 was $24.00M.
- BAXTER INTERNATIONAL INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2016 was $0.00.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $83.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $111.00M derived: sum of 2 quarters · filed 2022-02-23 | $111.00M derived: sum of 3 quarters · filed 2022-02-23 | $135.00M 10-K · filed 2022-02-23 | |
| 2021-09-30 | $28.00M 10-Q · filed 2021-10-28 | $28.00M derived: sum of 2 quarters · filed 2021-10-28 | $52.00M 10-Q · filed 2021-10-28 | $52.00M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2021-06-30 | $0.00 10-Q · filed 2021-07-29 | $24.00M 10-Q · filed 2021-07-29 | $24.00M derived: sum of 3 quarters · filed 2022-02-23 | $24.00M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2021-03-31 | $24.00M 10-Q · filed 2021-04-29 | $24.00M derived: sum of 2 quarters · filed 2022-02-23 | $24.00M derived: sum of 3 quarters · filed 2022-02-23 | $24.00M derived: sum of 4 quarters · filed 2022-02-23 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $0.00 derived: sum of 2 quarters · filed 2022-02-23 | $0.00 derived: sum of 3 quarters · filed 2022-02-23 | $4.00M 10-K · filed 2022-02-23 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-10-28 | $0.00 derived: sum of 2 quarters · filed 2021-10-28 | $4.00M 10-Q · filed 2021-10-28 | $22.00M derived: sum of 4 quarters · filed 2021-10-28 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-07-29 | $4.00M 10-Q · filed 2021-07-29 | $22.00M derived: sum of 3 quarters · filed 2021-07-29 | $22.00M derived: sum of 4 quarters · filed 2021-07-29 | |
| 2020-03-31 | $4.00M 10-Q · filed 2021-04-29 | $22.00M derived: sum of 2 quarters · filed 2021-04-29 | $22.00M derived: sum of 3 quarters · filed 2021-04-29 | $22.00M derived: sum of 4 quarters · filed 2021-04-29 | |
| 2019-12-31 | $18.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-04-29 | $18.00M derived: sum of 2 quarters · filed 2021-04-29 | $18.00M derived: sum of 3 quarters · filed 2021-04-29 | $18.00M 8-K · filed 2021-04-29 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-10-29 | $0.00 derived: sum of 2 quarters · filed 2020-10-29 | $0.00 10-Q · filed 2020-10-29 | $0.00 derived: sum of 4 quarters · filed 2020-10-29 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 | $0.00 derived: sum of 3 quarters · filed 2020-07-30 | $9.00M derived: sum of 4 quarters · filed 2020-07-30 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-04-30 | $0.00 derived: sum of 2 quarters · filed 2020-04-30 | $9.00M derived: sum of 3 quarters · filed 2020-04-30 | $9.00M derived: sum of 4 quarters · filed 2020-04-30 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $9.00M derived: sum of 2 quarters · filed 2020-03-17 | $9.00M derived: sum of 3 quarters · filed 2020-03-17 | $24.00M 10-K · filed 2020-03-17 | |
| 2018-09-30 | $9.00M 10-Q · filed 2020-03-17 | $9.00M derived: sum of 2 quarters · filed 2020-03-17 | $24.00M 10-Q · filed 2020-03-17 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-07-30 | $14.00M 10-Q · filed 2019-07-30 | |||
| 2018-03-31 | $14.00M 10-Q · filed 2019-05-08 | ||||
| 2016-12-31 | $0.00 10-K · filed 2017-02-23 | ||||
| 2015-12-31 | $0.00 10-K · filed 2017-02-23 | ||||
| 2014-12-31 | -$142.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | -$142.00M derived: sum of 2 quarters · filed 2016-02-26 | $0.00 10-K · filed 2016-02-26 | $142.00M 10-K · filed 2015-02-26 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $142.00M 10-Q · filed 2014-10-29 | |||
| 2014-06-30 | $142.00M 10-Q · filed 2014-07-30 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $2.00M derived: sum of 2 quarters · filed 2015-02-26 | -$56.00M derived: sum of 3 quarters · filed 2015-02-26 | $269.00M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$56.00M derived: sum of 2 quarters · filed 2013-10-30 | $269.00M 10-Q · filed 2013-10-30 | ||
| 2013-06-30 | -$58.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | $267.00M 10-Q · filed 2013-07-31 | |||
| 2013-03-31 | $325.00M 10-Q · filed 2013-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |